Evidence map›Paper›PMID 28241217›Full record

ArticleJAMA internal medicine2017

Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease.

Chien-Wen Tseng, Jinoos Yazdany, R Adams Dudley, Colette DeJong, Dhruv S Kazi, Randi Chen, Grace A Lin

Abstract read
In one paragraph

Article in JAMA internal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Health Care Spending on Respiratory Diseases in the United States, 1996-2016.American journal of respiratory and critical care medicine · 2023
    Article
  7. Article
  8. Coverage of New Drugs in Medicare Part D.The Milbank quarterly · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chien-Wen TsengDepartment of Family Medicine and Community Health, University of Hawaii John A. Burns School of Medicine, Honolulu.
Jinoos YazdanyDepartment of Medicine, University of California, San Francisco, San Francisco.
R Adams DudleyDepartment of Medicine, University of California, San Francisco, San Francisco.
Colette DeJongDepartment of Medicine, University of California, San Francisco, San Francisco.
Dhruv S KaziCenter for Vulnerable Populations, Department of Medicine (Cardiology), University of California, San Francisco.
Randi ChenPacific Health Research and Education Institute, Honolulu, Hawaii.
Grace A LinDepartment of Medicine, University of California, San Francisco, San Francisco.

Funding

ASPIRE: Advancing Safety Process Innovation in RheumatologyR01HS024412 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAZDANY, JINOOS · 2015 to 2017
$1.4M
AHRQ HHS K08 HS017723AHRQ HHS R01 HS024412AHRQ HHS R03 HS016772
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medicare Part DAdrenal Cortex HormonesAdrenergic beta-AgonistsCost SharingHumansMedicareMedication AdherenceNebulizers and VaporizersPulmonary Disease, Chronic ObstructiveUnited StatesAdrenal Cortex HormonesAdrenergic beta-Agonists

Identifiers

PMID28241217
PMCPMC6822611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.